Complications Associated With Perioperative Use of Tyrosine Kinase Inhibitor in Cytoreductive Nephrectomy

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-51548-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Erratum to Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Hypoalbuminaemia Is Associated With Mortality in Patients Undergoing Cytoreductive Nephrectomy

BJU International
Urology
2014English

P11 Tyrosine Kinase Inhibitor Use in Pulmonary Adenocarcinoma

Thorax
PulmonaryRespiratory Medicine
2013English

Trends in the Use of Cytoreductive Nephrectomy in the United States

Clinical Genitourinary Cancer
OncologyUrology
2012English

PVSS16. Perioperative Use of Dextran Is Associated With Cardiac Complications After Carotid Endarterectomy

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2012English

Cytoreductive Nephrectomy in the Modern Era: Predictors of Use, Morbidity, and Survival

Canadian Urological Association Journal
Urology
2017English

Cytoreductive Nephrectomy in the Current Treatment Algorithm

Therapeutic Advances in Medical Oncology
Oncology
2019English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy